S.Amdt. 1938Senate117th Congress (2021-2023)2nd degree
S.Amdt. 1938
Sponsored by
Sen. Marco Rubio (R-FL)
Submitted May 24, 2021
Legislative Activity
Stay on top of the latest movement without scrolling through every action
Floor
Latest Action
Senate amendment submitted
May 24, 2021
Text
Submitted
SA 1938. Mr. RUBIO submitted an amendment intended to be proposed to amendment SA 1502 proposed by Mr. Schumer to the bill S. 1260, to establish a new Directorate for Technology and Innovation in the National Science Foundation, to establish a regional technology hub program, to require a strategy and report on economic security, science, research, innovation, manufacturing, and job creation, to establish a critical supply chain resiliency program, and for other purposes; which was ordered to lie on the table; as follows: At the appropriate place in subtitle A of title I of division F, insert the following: SEC. 61__. ANNUAL REPORTING REGARDING GRANTEE TIES TO FOREIGN GOVERNMENTS. Title IV of the Public Health Service Act is amended by inserting after section 403C (42 U.S.C. 283a-2) the following: ``SEC. 403C-1. ANNUAL REPORTING REGARDING GRANTEE TIES TO FOREIGN GOVERNMENTS. ``(a) In General.--On an annual basis, the Director of NIH shall submit to the Committee on Health, Education, Labor, and Pensions, the Committee on Foreign Relations, and the Select Committee on Intelligence of the Senate, and to the Committee on Energy and Commerce, the Committee on Foreign Affairs, and the Permanent Select Committee on Intelligence of the House of Representatives, a report on any ties to foreign governments that researchers funded by grants from the National Institutes of Health have and that are not properly disclosed, vetted, and approved by the National Institutes of Health, including the status of any ongoing National Institutes of Health compliance reviews related to such ties and any administrative actions taken to address such concerns. ``(b) Requirement.--The Committees receiving the reports under subsection (a) shall keep confidential, and shall not release, any provision of such a report that is related to an ongoing National Institutes of Health compliance review.''. ______